Abstract:Objectives Genome sequencing is poised to be incorporated into clinical care for diagnoses of rare diseases and some cancers in many parts of the world. Healthcare professionals are key stakeholders in the clinical delivery of genome sequencing-based services. Our aim was to explore views of healthcare professionals with experience of offering genome sequencing via the 100 000 Genomes Project. Design Interview study using thematic analysis. Setting Four National Health Service hospitals in London. Participants Twenty-three healthcare professionals (five genetic clinicians and eight non-genetic clinicians (all consultants), and 10 ‘consenters’ from a range of backgrounds) involved in identifying or consenting patients for the 100 000 Genomes Project. Results Most participants expressed positive attitudes towards genome sequencing in terms of improved ability to diagnose rare diseases, but many also expressed concerns, with some believing its superiority over exome sequencing had not yet been demonstrated, or worrying that non-genetic clinicians are inadequately prepared to discuss genome sequencing results with patients. Several emphasised additional evidence about utility of genome sequencing in terms of both main and secondary findings is needed. Most felt non-genetic clinicians could support patients during consent, as long as they have appropriate training and support from genetic teams. Many stated genetics experts will play a vital role in training and supporting non-genetic clinicians in variant interpretation and results delivery, particularly for more complex cases. Conclusions Healthcare professionals responsible for delivering clinical genome sequencing have largely positive views about the potential for genome sequencing to improve diagnostic yield, but also significant concerns about practical aspects of offering these tests. Non-genetic clinicians delivering genome sequencing require guidance and support. Additional empirical evidence is needed to inform policy and practice, including how genome compares to exome sequencing; utility of secondary findings; training, in particular of non-genetic health professionals; and mechanisms whereby genetics teams can offer appropriate support to their non-genetics colleagues.

Integrating Genomics into Healthcare: A Global Responsibility

From theory to practice: Implementing next-generation sequencing and public health genomics in healthcare systems

Genomes in clinical care

A call to action to scale up research and clinical genomic data sharing

Implementing genomic medicine in New Zealand

Primary Care Implementation of Genomic Population Health Screening Using a Large Gene Sequencing Panel

"A very big challenge": a qualitative study to explore the early barriers and enablers to implementing a national genomic medicine service in England

Pulling the Strands Together: MEGA Steps to Drive European Genomics and Personalised Medicine

Genetics and primary care: where are we headed?

The impact of genomics on public health practice

Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research

Enabling responsible public genomics

Managing expectations, rights, and duties in large-scale genomics initiatives: a European comparison

Establishing an infrastructure to optimize the integration of genomics into research: Results from a precision health needs assessment

Delivering genome sequencing in clinical practice: an interview study with healthcare professionals involved in the 100 000 Genomes Project

From Genetics to Genomics: Facing the Liability Implications in Clinical Care

Identifying Aspects of Public Attitudes Toward Whole Genome Sequencing to Inform the Integration of Genomics into Care

The role of genomics in global cancer prevention

Progress toward Health System Readiness for Genome-Based Testing in Canada

A Roadmap for Global Acceleration of Genomics Integration Across Nursing

Advancing genomics to improve health equity